...
Inhibition of GSK-3 ameliorates the pathogenesis of Huntington's disease
Age-related and disease locus-specific mechanisms contribute to early remodelling of...
Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models...
Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington's...
The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin
Beneficial effects of glatiramer acetate in Huntington’s disease mouse models: Evidence...
Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal...
miR-196a Ameliorates Phenotypes of Huntington Disease in Cell, Transgenic Mouse, and...
Significantly differential diffusion of neuropathological aggregates in the brain of...